1. 3-Dimensional target coverage assessment for MRI guided esophageal cancer radiotherapy. (June 2020) Authors: Boekhoff, M.R.; Defize, I.L.; Borggreve, A.S.; Takahashi, N.; van Lier, A.L.H.M.W.; Ruurda, J.P.; van Hillegersberg, R.; Lagendijk, J.J.W.; Mook, S.; Meijer, G.J. Journal: Radiotherapy and oncology Issue: Volume 147(2020) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation. (May 2022) Authors: Boekhoff, M.R.; Bouwmans, R.; Doornaert, P.A.H.; Intven, M.P.W.; Lagendijk, J.J.W.; van Lier, A.L.H.M.W.; Rasing, M.J.A.; van de Ven, S.; Meijer, G.J.; Mook, S. Journal: Clinical and translational radiation oncology Issue: Volume 34(2022) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CTV-to-PTV margin assessment for esophageal cancer radiotherapy based on an accumulated dose analysis. (August 2021) Authors: Boekhoff, M.R.; Defize, I.L.; Borggreve, A.S.; van Hillegersberg, R.; Kotte, A.N.T.J.; Lagendijk, J.J.W.; van Lier, A.L.H.M.W.; Ruurda, J.P.; Takahashi, N.; Mook, S.; Meijer, G.J. Journal: Radiotherapy and oncology Issue: Volume 161(2021) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗